STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Axcelis Announces Financial Results for Third Quarter 2025

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Axcelis (Nasdaq: ACLS) reported third-quarter 2025 results with revenue of $213.6 million, GAAP gross margin of 41.6% and GAAP diluted EPS of $0.83. Non-GAAP diluted EPS was $1.21 and Adjusted EBITDA was $43.2 million. Management highlighted record CS&I revenue, strong operating leverage, and over $590 million in cash and investments on the balance sheet.

The company provided fourth-quarter 2025 guidance of approximately $215 million revenue, GAAP EPS of about $0.76, and non-GAAP EPS of about $1.12. Management reiterated the proposed merger with Veeco Instruments as a strategic milestone intended to create a larger semiconductor equipment company.

Axcelis (Nasdaq: ACLS) ha riportato i risultati del terzo trimestre 2025 con entrate di 213,6 milioni di dollari, margine lordo GAAP del 41,6% e utile per azione diluito GAAP di 0,83 dollari. L'utile diluito non GAAP è stato 1,21 dollari e l'EBITDA rettificato è stato 43,2 milioni di dollari. Il management ha evidenziato fatturato record CS&I, forte leva operativa e oltre 590 milioni di dollari in liquidità e investimenti nel bilancio.

La società ha fornito una guidance per il quarto trimestre 2025 di circa 215 milioni di dollari di entrate, un GAAP EPS di circa 0,76 dollari e un non-GAAP EPS di circa 1,12 dollari. Il management ha ribadito la fusione proposta con Veeco Instruments come una tappa strategica finalizzata a creare una più grande azienda di apparecchiature per semiconduttori.

Axcelis (Nasdaq: ACLS) reportó resultados del tercer trimestre de 2025 con ingresos de 213,6 millones de dólares, margen bruto GAAP del 41,6% y EPS diluido GAAP de 0,83 dólares. El EPS diluido no GAAP fue 1,21 dólares y el EBITDA ajustado fue 43,2 millones de dólares. La dirección destacó ingresos CS&I récord, una fuerte palanca operativa y más de 590 millones de dólares en efectivo e inversiones en el balance.

La compañía proporcionó una guía para el cuarto trimestre de 2025 de aproximadamente 215 millones de dólares de ingresos, un EPS GAAP de alrededor de 0,76 dólares, y un EPS no GAAP de alrededor de 1,12 dólares. La dirección reiteró la fusión propuesta con Veeco Instruments como un hito estratégico destinado a crear una empresa de equipos para semiconductores de mayor tamaño.

Axcelis (나스닥: ACLS)는 2025년 3분기 실적을 발표했습니다. 매출 213.6백만 달러, GAAP 총 이익률 41.6%, GAAP 희석 EPS 0.83 달러로 발표했습니다. Non-GAAP 희석 EPS는 1.21 달러였고 조정 EBITDA는 43.2백만 달러였습니다. 경영진은 CS&I 매출 기록, 강한 영업 레버리지, 그리고 대차대조표상의 현금 및 투자액이 59억 달러를 넘어섰다고 강조했습니다.

회사은 2025년 4분기 가이던스로 매출 약 215백만 달러, GAAP EPS 약 0.76 달러, 비GAAP EPS 약 1.12 달러를 제시했습니다. 경영진은 Veeco Instruments와의 예비 합병을 더 큰 반도체 제조장비 회사로 만들기 위한 전략적 이정표로 재확인했습니다.

Axcelis (Nasdaq : ACLS) a publié les résultats du troisième trimestre 2025 avec un chiffre d'affaires de 213,6 millions de dollars, une marge brute GAAP de 41,6% et un BPA dilué GAAP de 0,83 USD. Le BPA dilué non-GAAP était 1,21 USD et l'EBITDA ajusté était 43,2 millions USD. La direction a souligné un chiffre d'affaires CS&I record, une forte leverage opérationnelle et plus de 590 millions USD en liquidités et investissements au bilan.

La société a fourni des prévisions pour le quatrième trimestre 2025 d'environ 215 millions USD de chiffre d'affaires, un BPA GAAP d'environ 0,76 USD et un BPA non-GAAP d'environ 1,12 USD. La direction a réaffirmé la fusion proposée avec Veeco Instruments comme une étape stratégique visant à créer une entreprise d'équipements pour semi-conducteurs plus importante.

Axcelis (Nasdaq: ACLS) meldete die Ergebnisse des dritten Quartals 2025 mit Umsatz von 213,6 Mio. USD, GAAP-Bruttomarge von 41,6% und GAAP-dilutiertem EPS von 0,83 USD. Non-GAAP dilutiertes EPS betrug 1,21 USD und bereinigtes EBITDA 43,2 Mio. USD. Das Management hob rekordhohen CS&I-Umsatz, starke operative Hebelwirkung und mehr als 590 Mio. USD an Bargeld und Investments in der Bilanz hervor.

Für das vierte Quartal 2025 gab das Unternehmen eine Prognose von ca. 215 Mio. USD Umsatz, GAAP-EPS ca. 0,76 USD und Non-GAAP EPS ca. 1,12 USD bekannt. Das Management bekräftigte die vorgesehene Fusion mit Veeco Instruments als strategischen Meilenstein, um ein größeres Halbleiter-Ausrüstungsunternehmen zu schaffen.

أكسيليس (نيسدك: ACLS) أعلنت عن نتائج الربع الثالث من 2025 مع إيرادات قدرها 213.6 مليون دولار، وهامش إجمالي GAAP بنسبة 41.6% وربحية السهم المخفف GAAP قدرها 0.83 دولار. ربحية السهم المخففة غير GAAP كانت 1.21 دولار وEBITDA المعدلة كانت 43.2 مليون دولار. أشارت الإدارة إلى إيرادات CS&I قياسية، وتحسن تشغيلي قوي وأكثر من 590 مليون دولار من النقد والاستثمارات في الميزانية.

قدمت الشركة توجيهات للربع الرابع من 2025 تقارب 215 مليون دولار من الإيرادات، وربحية السهم GAAP حوالي 0.76 دولار، وربحية السهم غير GAAP حوالي 1.12 دولار. كرّرت الإدارة دمجها المقترح مع Veeco Instruments كمرحلة استراتيجية تهدف إلى إنشاء شركة معدات للدوائر المتكاملة أكبر.

Positive
  • Cash & investments > $590 million
  • Q4 revenue guidance ~ $215 million
  • Recorded CS&I revenue high in the quarter
Negative
  • Revenue down ~16.7% YoY ($256.6M to $213.6M)
  • GAAP net income down ~46% YoY ($48.6M to $26.0M)
  • GAAP diluted EPS down ~44% YoY ($1.49 to $0.83)
  • Adjusted EBITDA down ~27.6% YoY ($59.7M to $43.2M)

Insights

Mixed quarterly results: revenues and EPS fell year‑over‑year but strong cash, free cash flow and a planned merger change the picture.

Axcelis reported $213.6 million revenue for Q3 and GAAP diluted EPS of $0.83, down from prior-year figures. GAAP gross margin was 41.6% and GAAP operating margin was 11.7%; non-GAAP EPS was $1.21. The company cites record CS&I revenue and disciplined cost control as drivers of operating leverage.

Key dependencies and risks remain explicit: fourth-quarter guidance of approximately $215 million revenue, GAAP EPS $0.76, and non-GAAP EPS $1.12 will test momentum. The announced merger with Veeco and the stated $590 million in cash and investments are material facts that could affect capital allocation and integration-related costs. Monitor regulatory approvals, conversion of backlog to revenue, and Q4 margin trends over the next quarter.

Q3 Highlights:

BEVERLY, Mass., Nov. 4, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS) today announced financial results for the third quarter ended September 30, 2025.

President and CEO Russell Low commented, "We delivered another solid quarter, with sales and earnings both exceeding our expectations. We are also pleased to report record CS&I revenue in the quarter, reflecting the success of our aftermarket strategy and the continued expansion of our installed base. We are executing on our product development roadmap and customer engagement initiatives with focus and urgency, while maintaining disciplined cost controls. These actions have enabled us to successfully navigate the anticipated cyclical digestion period across our markets in 2025."

Low added, "We entered the fourth quarter with a solid financial foundation and are well poised to execute on our strategy as we enter into our next chapter of growth and innovation. Our recently announced merger with Veeco Instruments marks a critical milestone that we believe will position the combined company to capitalize on powerful secular tailwinds including AI and electrification. By bringing our two companies together, we believe we are building a leading semiconductor equipment company with the capabilities, resources and financial foundation to drive sustainable growth and value creation for shareholders and deliver meaningful benefits to all stakeholders."

Executive Vice President and Chief Financial Officer Jamie Coogan stated, "We generated robust operating leverage through higher volume and disciplined cost management, translating into strong free cash flow. With over $590 million in cash and investments on the balance sheet, Axcelis has ample flexibility to capitalize on our value-enhancing strategic initiatives and long-term growth priorities."

Results Summary 

(In thousands, except per share amounts and percentages)




Three months ended September 30,



2025



2024


Revenue

$

213,611


$

256,564


Gross margin


41.6 %



42.9 %


Operating margin


11.7 %



18.3 %


Net income

$

25,986


$

48,576


Diluted earnings per share

$

0.83


$

1.49


 Non-GAAP Results


Non-GAAP gross margin


41.8 %



43.0 %

Non-GAAP operating margin


18.2 %



21.7 %

Adjusted EBITDA

$

43,202


$

59,674

Non-GAAP net income

$

37,900


$

56,191

Non-GAAP diluted earnings per share

$

1.21


$

1.72

 

Business Outlook
For the fourth quarter ending December 31, 2025, Axcelis expects revenues of approximately $215 million, GAAP earnings per diluted share of approximately $0.76, and non-GAAP earnings per share of approximately $1.12.

Please refer to Fourth Quarter Outlook under the "Notes on our Non-GAAP Financial Information" section of this document for detail relating to the computation of non-GAAP earnings per diluted share as well as the Safe Harbor Statement section of this document.

Third Quarter 2025 Conference Call
The Company will host a call today to discuss the results at 8:30 a.m. ET. The call will be available via webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by registering as a participant here:

https://register-conf.media-server.com/register/BI7b3b54c06ff14c8080f379ce76dc7cab
Webcast replays will be available for 30 days following the call.

Use of Non-GAAP Financial Results
This press release includes financial measures that are not presented in accordance with U.S. generally accepted accounting principles ("non-GAAP financial measures"). These non-GAAP financial measures include non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating income, non-GAAP operating margin, non-GAAP income tax provision, Adjusted EBITDA, non-GAAP net income, and non-GAAP diluted earnings per share, and reflect adjustments for the impact of share-based compensation expense, certain items related to restructuring and severance charges and any associated adjustments and transaction and integration costs associated with the merger agreement with Veeco Instruments announced on October 1, 2025.

Reconciliations of these non-GAAP financial measures to the most directly comparable financial measures calculated and presented in accordance with GAAP are provided in the financial tables included in this release.

For further information regarding these non-GAAP financial measures, please refer to the tables presenting reconciliations of our non-GAAP results to our GAAP results and the "Notes on Our Non-GAAP Financial Information" at the end of this press release.

Safe Harbor Statement
This press release contains, and the conference call will contain, forward-looking statements under the Private Securities Litigation Reform Act safe harbor provisions. These statements, which include our expectations for spending in our industry and guidance for future financial performance, are based on management's current expectations and should be viewed with caution. They are subject to various risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are outside the control of the Company, including that customer decisions to place orders or our product shipments may not occur when we expect, that orders may not be converted to revenue in any particular quarter, or at all, whether demand will continue for the semiconductor equipment we produce or, if not, whether we can successfully meet changing market requirements, and whether we will be able to maintain continuity of business relationships with and purchases by major customers and, with respect to the potential transaction with Veeco, failure to obtain applicable regulatory or stockholder approvals in a timely manner or otherwise; failure to satisfy other closing conditions to the proposed transaction or to complete the proposed transaction on anticipated terms and timing; negative effects of the announcement of the proposed transaction; risks that the businesses will not be integrated successfully or that the combined company will not realize expected benefits, cost savings, accretion, synergies and/or growth, or that such benefits may take longer to realize or may be more costly to achieve than expected; the risk that disruptions from the proposed transaction will harm business plans and operations; risks relating to unanticipated costs of integration; significant transaction and/or integration costs, or difficulties in connection with the proposed transaction and/or unknown or inestimable liabilities; restrictions during the pendency of the proposed transaction that may impact the ability to pursue certain business opportunities or strategic transactions; potential litigation associated with the proposed transaction; the potential impact of the announcement or consummation of the proposed transaction on the Company's, Veeco's or the combined company's relationships with suppliers, customers, employees and regulators; and demand for the combined company's products. Actual results may differ materially from those projected in such statements due to various factors, including but not limited to: economic, political and social conditions in the countries in which the Company and Veeco, their respective customers and suppliers operate; disruption to the Company's and Veeco's respective manufacturing facilities or other operations, or the operations of Company's and Veeco's respective customers and suppliers, due to natural catastrophic events, health epidemics or terrorism; ongoing changes in the technology industry, and the semiconductor industry in particular, including future growth rates, pricing trends in end-markets, or changes in customer capital spending patterns; the Company's, Veeco's and the combined company's ability to timely develop new technologies and products that successfully anticipate or address changes in the semiconductor industry; the Company's, Veeco's and the combined company's ability to maintain their respective technology advantage and protect their respective proprietary rights; the Company's, Veeco's and the combined company's ability to compete with new products introduced by their respective competitors; the Company's, Veeco's and the combined company's ability or the ability of their respective customers to obtain U.S. export control licenses for the sale of certain products or provision of certain services to customers in China. Increased competitive pressure on sales and pricing, increases in material and other production costs that cannot be recouped in product pricing and instability caused by changing global economic, political or financial conditions, including with respect to the imposition of tariffs on our products or components of our products, could also cause actual results to differ materially from those in our forward-looking statements. These risks and other risk factors relating to Axcelis are described more fully in the most recent Form 10-K filed by Axcelis and in other documents filed from time to time with the Securities and Exchange Commission.

About Axcelis:

Axcelis (Nasdaq: ACLS), headquartered in Beverly, Mass., has been providing innovative, high-productivity solutions for the semiconductor industry for over 45 years. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the most critical and enabling steps in the IC manufacturing process. Learn more about Axcelis at www.axcelis.com.

CONTACTS:

Investor Relations Contact:
David Ryzhik
Senior Vice President, Investor Relations and Corporate Strategy
Telephone: (978) 787-2352
Email: David.Ryzhik@axcelis.com

Press/Media Relations Contact:
Maureen Hart
Senior Director, Corporate & Marketing Communications
Telephone: (978) 787-4266
Email: Maureen.Hart@axcelis.com

Axcelis Technologies, Inc.
Consolidated Statements of Operations
(In thousands, except per share amounts)
(Unaudited)






Three months ended


Nine months ended





September 30,


September 30,




2025


2024


2025


2024


Revenue:














Product


$

201,218


$

246,826


$

567,444


$

735,626


Services



12,393



9,738



33,274



29,822


Total revenue



213,611



256,564



600,718



765,448


Cost of revenue:














Product



112,078



136,379



302,041



399,049


Services



12,727



10,215



33,761



27,968


Total cost of revenue



124,805



146,594



335,802



427,017


Gross profit



88,806



109,970



264,916



338,431


Operating expenses:














Research and development



24,640



26,395



78,832



77,843


Sales and marketing



15,838



16,808



45,965



51,483


General and administrative



23,308



19,854



56,976



52,842


Total operating expenses



63,786



63,057



181,773



182,168


Income from operations



25,020



46,913



83,143



156,263


Other income (expense):














Interest income



5,465



6,560



16,547



18,126


Interest expense



(1,305)



(1,333)



(4,028)



(4,017)


Other, net



970



3,225



2,569



1,257


Total other income



5,130



8,452



15,088



15,366


Income before income taxes



30,150



55,365



98,231



171,629


Income tax provision



4,164



6,789



12,290



20,593


Net income


$

25,986


$

48,576


$

85,941


$

151,036


Net income per share:














Basic


$

0.83


$

1.49


$

2.70


$

4.63


Diluted


$

0.83


$

1.49


$

2.70


$

4.61


Shares used in computing net income per share:














Basic weighted average shares of common stock



31,287



32,550



31,796



32,595


Diluted weighted average shares of common stock



31,450



32,675



31,863



32,780


 

Axcelis Technologies, Inc.
Consolidated Balance Sheets
(In thousands, except per share amounts)
(Unaudited)






September 30,


December 31,




2025


2024


ASSETS


Current assets:








Cash and cash equivalents


$

187,501


$

123,512


Short-term investments



262,059



447,831


Accounts receivable, net



147,636



203,149


Inventories, net



324,342



282,225


Prepaid income taxes



4,687



6,420


Prepaid expenses and other current assets



57,804



60,471


Total current assets



984,029



1,123,608


Property, plant and equipment, net



57,979



53,784


Operating lease assets



29,499



29,621


Finance lease assets, net



14,440



15,346


Long-term restricted cash



7,626



7,552


Deferred income taxes



70,033



68,277


Long-term investments



143,214



-


Other assets



45,120



50,593


Total assets


$

1,351,940


$

1,348,781


LIABILITIES AND STOCKHOLDERS' EQUITY


Current liabilities:








Accounts payable


$

52,466


$

46,928


Accrued compensation



24,357



25,536


Warranty



9,258



13,022


Deferred revenue



81,486



94,673


Current portion of finance lease obligation



1,505



1,345


Other current liabilities



29,917



26,018


Total current liabilities



198,989



207,522


Long-term finance lease obligation



41,166



42,329


Long-term deferred revenue



47,434



43,501


Other long-term liabilities



44,207



42,639


Total liabilities



331,796



335,991










Stockholders' equity:








Common stock, $0.001 par value, 75,000 shares authorized; 30,998 shares issued and
outstanding at September 30, 2025; 32,365 shares issued and outstanding at December 31,
2024



31



32


Additional paid-in capital



532,951



548,654


Retained earnings



488,771



470,318


Accumulated other comprehensive loss



(1,609)



(6,214)


Total stockholders' equity



1,020,144



1,012,790


Total liabilities and stockholders' equity


$

1,351,940


$

1,348,781










 

Axcelis Technologies, Inc.
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)



Three months ended



Nine months ended




September 30,



September 30,




2025


2024



2025



2024



Cash flows from operating activities













Net income

$

25,986


$

48,576


$

85,941


$

151,036


Adjustments to reconcile net income to net cash provided by operating
activities:













Depreciation and amortization


4,328



3,906



13,152



11,542


Stock-based compensation expense


5,344



5,412



15,668



15,571


Other


6,907



(16,346)



(4,110)



(11,090)


Change in other assets and liabilities, net


2,785



4,200



14,221



(39,021)


Net cash provided by operating activities


45,350



45,748



124,872



128,038















Cash flows from investing activities













Expenditures for property, plant and equipment and capitalized software


(2,015)



(3,899)



(8,960)



(7,523)


Other changes in investing activities, net


3,393



(52,654)



46,194



(110,324)


Net cash provided by (used in) investing activities


1,378



(56,553)



37,234



(117,847)















Cash flows from financing activities













Repurchase of common stock


(32,335)



(15,363)



(95,850)



(45,358)


Other changes from financing activities, net


(440)



(630)



(4,022)



(11,291)


Net cash used in financing activities


(32,775)



(15,993)



(99,872)



(56,649)















Effect of exchange rate changes on cash and cash equivalents


(106)



1,700



1,829



(774)


Net increase (decrease) in cash, cash equivalents and restricted cash


13,847



(25,098)



64,063



(47,232)















Cash, cash equivalents and restricted cash at beginning of period


181,280



151,817



131,064



173,951


Cash, cash equivalents and restricted cash at end of period

$

195,127


$

126,719


$

195,127


$

126,719






















 

Notes on Our Non-GAAP Financial Information

Management uses non-GAAP gross profit, gross margin, operating income, operating margin, income tax provision, net income, diluted earnings per share, and Adjusted EBITDA to evaluate the Company's operating and financial performance and for planning purposes. Axcelis believes these measures enhance an overall understanding of its performance and investors' ability to review the Company's business from the same perspective as the Company's management. 

There are limitations in using non-GAAP financial measures because the non-GAAP financial measures are not prepared in accordance with GAAP, may be different from non-GAAP financial measures used by other companies, and may exclude certain items that may have a material impact upon our reported financial results. The presentation of this additional information is not meant to be considered in isolation or as a substitute for the directly comparable financial measures prepared in accordance with GAAP.

Totals presented may not sum and percentages may not recalculate using figures presented due to rounding.

Axcelis Technologies, Inc.
Schedule Reconciling Selected Non-GAAP Financial Measures
(In thousands, except per share amounts)





Three months ended September 30,




Nine months ended September 30,




2025



2024



2025



2024

GAAP gross Profit

$

88,806


$

109,970


$

264,916


$

338,431

Restructuring1


-



-



226



876

Stock-based compensation


499



354



1,421



1,106

Non-GAAP gross profit

$

89,305


$

110,324


$

266,563


$

340,413

Non-GAAP gross margin


41.8 %



43.0 %



44.4 %



44.5 %













GAAP operating expense

$

63,786


$

63,057


$

181,773


$

182,168

Transaction and integration3


(8,274)



-



(8,274)



-

Bad debt expense


-



(3,443)



-



(2,984)

Restructuring1


(236)



-



(1,130)



(553)

Stock-based compensation


(4,845)



(5,058)



(14,247)



(14,465)

Non-GAAP operating expense

$

50,431


$

54,556


$

158,122


$

164,166













GAAP operating income

$

25,020


$

46,913


$

83,143


$

156,263

Transaction and integration3


8,274



-



8,274



-

Bad debt expense


-



3,443



-



2,984

Restructuring1


236



-



1,356



1,429

Stock-based compensation


5,344



5,412



15,668



15,571

Non-GAAP operating income

$

38,874


$

55,768


$

108,441


$

176,247

Non-GAAP operating margin


18.2 %



21.7 %



18.1 %



23.0 %













GAAP income tax provision

$

4,164


$

6,789


$

12,290


$

20,593

Income tax effect of Non-GAAP
adjustments2


1,940



1,240



3,542



2,798

Non-GAAP income tax provision

$

6,104


$

8,029


$

15,832


$

23,391













GAAP net income

$

25,986


$

48,576


$

85,941


$

151,036

Transaction and integration3


8,274



-



8,274



-

Bad debt expense


-



3,443



-



2,984

Restructuring1


236



-



1,356



1,429

Stock-based compensation


5,344



5,412



15,668



15,571

Income tax effect of Non-GAAP
adjustments2


(1,940)



(1,240)



(3,542)



(2,798)

Non-GAAP net income

$

37,900


$

56,191


$

107,697


$

168,222













GAAP diluted EPS

$

0.83


$

1.49


$

2.70


$

4.61

Transaction and integration3


0.26



-



0.26



-

Bad debt expense


-



0.11



-



0.09

Restructuring1


0.01



-



0.04



0.04

Stock-based compensation


0.17



0.16



0.49



0.48

Income tax effect of Non-GAAP
adjustments2


(0.06)



(0.04)



(0.11)



(0.09)

Non-GAAP diluted EPS

$

1.21


$

1.72


$

3.38


$

5.13
























Note 1: Restructuring and other costs primarily related to early retirement programs and severance costs, due to global cost-saving initiatives.

Note 2: Impact of taxes from non-GAAP adjustments, uses adjusted tax rate of 14%.

Note 3: Transaction and integration costs include expenses associated with the merger agreement with Veeco Instruments, announced on October 1,
2025.

 



 

 

Axcelis Technologies, Inc

Reconciliation of Net Income to Adjusted EBITDA

(In thousands, except percentages)

 





Three months ended September 30,




Nine months ended September 30,




2025



2024



2025



2024

Net Income

$

25,986


$

48,576


$

85,941


$

151,036

Other (income)/expense


(5,130)



(8,452)



(15,088)



(15,366)

Income tax provision


4,164



6,789



12,290



20,593

Depreciation & amortization


4,328



3,906



13,152



11,542

Subtotal


29,348



50,819



96,295



167,805

Transaction and integration2


8,274



-



8,274



-

Bad debt expense


-



3,443



-



2,984

Restructuring1


236



-



1,356



1,429

Stock-based compensation


5,344



5,412



15,668



15,571

Adjusted EBITDA

$

43,202


$

59,674


$

121,593


$

187,789

Adjusted EBITDA margin


20.2 %



23.3 %



20.2 %



24.5 %





















Note 1: Restructuring and other costs primarily related to early retirement programs and severance costs, due to global cost-saving initiatives.

Note 2: Transaction and integration costs include expenses associated with the merger agreement with Veeco Instruments, announced on October 1,
2025.

 







 

Axcelis Technologies, Inc

Fourth Quarter Outlook

GAAP to Non-GAAP Diluted Earnings Per Share

 



Three months ended

December 31, 2025


GAAP diluted EPS

$

0.76


Transaction and Integration2


0.19


Restructuring3


0.05


Stock-based compensation


0.18


Income tax effect of non-GAAP adjustments1

(0.06)


Non-GAAP diluted EPS

$

1.12









Note 1: Impact of taxes from non-GAAP adjustments, uses adjusted tax rate of 14%.

Note 2: Transaction and Integration costs include expenses associated with the merger agreement with Veeco Instruments, announced on October 1,
2025.

Note 3: Restructuring and other costs primarily related to early retirement programs and severance costs, due to global cost-saving initiatives.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/axcelis-announces-financial-results-for-third-quarter-2025-302603601.html

SOURCE Axcelis Technologies, Inc.

FAQ

What were Axcelis (ACLS) Q3 2025 revenue and GAAP EPS?

Axcelis reported $213.6 million in revenue and GAAP diluted EPS of $0.83 for Q3 2025.

How did Axcelis (ACLS) Q3 2025 non-GAAP results compare to last year?

Non-GAAP diluted EPS was $1.21 versus $1.72 in Q3 2024, a decline of about 29.7%.

What guidance did Axcelis (ACLS) give for Q4 2025?

Axcelis expects Q4 2025 revenue of approximately $215 million, GAAP EPS ~$0.76, non-GAAP EPS ~$1.12.

How much cash did Axcelis (ACLS) report on its balance sheet in Q3 2025?

Management reported more than $590 million in cash and investments.

What operational positives did Axcelis (ACLS) cite in the Q3 2025 release?

The company cited record CS&I revenue, operating leverage from higher volume, and disciplined cost controls.

What is the status of Axcelis (ACLS) merger with Veeco and its expected impact?

Axcelis described the announced merger with Veeco as a strategic milestone intended to create a larger semiconductor equipment company to pursue growth from AI and electrification tailwinds.
Axcelis Tech Ord

NASDAQ:ACLS

ACLS Rankings

ACLS Latest News

ACLS Latest SEC Filings

ACLS Stock Data

2.62B
30.48M
1.64%
105.03%
14.54%
Semiconductor Equipment & Materials
Special Industry Machinery, Nec
Link
United States
BEVERLY